Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique (CT DOSE)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a prospective, controlled observational trial of patients undergoing clinically indicated cardiothoracic computed tomography (CT), including pulmonary or aortic angiography and coronary CT angiography (CCTA).
| Condition |
|---|
|
Coronary Artery Disease Aortic Aneurysm Pulmonary Embolism |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique Employed in Cardiothoracic Imaging |
- Radiation dose [ Time Frame: Time of CT scan ] [ Designated as safety issue: Yes ]The primary endpoint is radiation dose, measured as dose-length-product (DLP, in mGy∙cm) and effective radiation dose, calculated as DLP x 0.014 (in mSv).
- Assessment of Image Quality [ Time Frame: Time of CT Scan ] [ Designated as safety issue: No ]Signal noise (standard deviation of attenuation in Hounsfield units) will be determined in regions of interest in: A) air anterior to the chest wall, B) mid-LV septum and C) mid thoracic aorta or main PA. This will be done in a sequential sample of every 5th case (approximately 600 cases total).
| Estimated Enrollment: | 3000 |
| Study Start Date: | January 2011 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Control Group
Data from patients in the control group will be obtained retrospectively from patient medical records and stored image data
|
|
Prospective Patient Group
Data from patients in the Flash group will be obtained prospectively from scanner consoles and medical records.
|
Detailed Description:
The development of a novel CT scanner capable of sequential or fast-pitch spiral techniques in most patients (Siemens Definition Flash) represents a potentially crucial technical innovation at a particularly critical juncture. National healthcare systems are under pressure to deliver accurate and cost-effective diagnosis of an increasing number of patients and CT angiography in various settings is a proven, highly accurate technique that has been shown to improve diagnostic efficiency and reduce the cost of care.
However, there has been increasing concern about the lifetime attributable risk of cancer from radiation related to diagnostic procedures. Such concern extends to other radiation-based procedures that contribute to the cumulative lifetime radiation exposure of patients. The Flash scanner holds the promise of substantially reducing exposure resulting from a variety of examinations.
The CT DOSE multicenter trial is therefore designed to validate the extent of dose reduction attendant to the use of the Flash scanner in cardiothoracic scanning, and to determine whether image quality is preserved in spite of significant dose reduction.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients undergoing clinically indicated cardiothoracic computed tomography (CT), including pulmonary or aortic angiography and coronary CT angiography (CCTA)at 10 sites. Patient selection will be based on a site consecutive CT scan log.
Inclusion Criteria:
- Scans from patients undergoing clinically indicated pulmonary angiography, aortography and/or CCTA.
- Age greater than or equal to 18 years.
Exclusion Criteria:
- No exclusions
Contacts and Locations| Contact: Ann DePetris, RN, MSA | 248.551.6683 | ann.depetris@beaumont.edu |
| United States, California | |
| Naval Medical Center | Completed |
| San Diego, California, United States, 92134 | |
| United States, Massachusetts | |
| Massachusetts General Hospital | Completed |
| Boston, Massachusetts, United States, 02114 | |
| United States, Michigan | |
| William Beaumont Hospital-Royal Oak | Completed |
| Royal Oak, Michigan, United States, 48073 | |
| William Beaumont Hospital-Troy | Completed |
| Troy, Michigan, United States, 48085 | |
| United States, Minnesota | |
| Minneapolis Heart Institute/ Abbott Northwestern | Completed |
| Minneapolis, Minnesota, United States, 55407 | |
| United States, New York | |
| NYU Langone Medical Center | Completed |
| New York, New York, United States, 10006 | |
| United States, Ohio | |
| Cleveland Clinic Foundation | Recruiting |
| Cleveland, Ohio, United States, 44195 | |
| Contact: Sandra Halliburton, PhD HALLIBS@ccf.org | |
| Principal Investigator: Sandra Halliburton, PhD | |
| United States, South Carolina | |
| Medical University of South Carolina | Completed |
| Charleston, South Carolina, United States, 29425 | |
| Saudi Arabia | |
| King Abdul-Aziz Cardiac Center, national Guard Health Affairs | Completed |
| Riyadh, Kingdom of Saudi Arabia, Saudi Arabia, 11426 | |
| Principal Investigator: | Gilbert Raff, MD | William Beaumont Hospitals |
More Information
No publications provided
| Responsible Party: | Gilbert L. Raff, MD, Medical Director, Advanced Cardiovascular Imaging, William Beaumont Hospitals |
| ClinicalTrials.gov Identifier: | NCT01272453 History of Changes |
| Other Study ID Numbers: | 2010-209 |
| Study First Received: | January 6, 2011 |
| Last Updated: | September 26, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by William Beaumont Hospitals:
|
coronary artery disease CT scan coronary angiography |
chest pain aortic aneurysm pulmonary embolism |
Additional relevant MeSH terms:
|
Aneurysm Aortic Aneurysm Coronary Artery Disease Myocardial Ischemia Coronary Disease Embolism Pulmonary Embolism Vascular Diseases |
Cardiovascular Diseases Aortic Diseases Heart Diseases Arteriosclerosis Arterial Occlusive Diseases Embolism and Thrombosis Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 17, 2013